Evidence map›Paper›PMID 38474395›Full record

ArticleCells2024

The Role of β-Dystroglycan in Nuclear Dynamics.

Matthew Cook, Ben Stevenson, Laura A Jacobs, Daniel Leocadio Victoria, Bulmaro Cisneros, Jamie K Hobbs, Colin L Stewart, Steve J Winder

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Matthew CookSchool of Biosciences, University of Sheffield, Sheffield S10 2TN, UK.
Ben StevensonSchool of Biosciences, University of Sheffield, Sheffield S10 2TN, UK.
Laura A JacobsSchool of Biosciences, University of Sheffield, Sheffield S10 2TN, UK.
Daniel Leocadio VictoriaSchool of Biosciences, University of Sheffield, Sheffield S10 2TN, UK.
Bulmaro CisnerosDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados, Mexico City 07360, Mexico.
Jamie K HobbsDepartment of Physics and Astronomy, University of Sheffield, Sheffield S3 7RH, UK.
Colin L StewartA*STAR Skin Research Laboratories, Singapore 138648, Singapore.
Steve J WinderSchool of Biosciences, University of Sheffield, Sheffield S10 2TN, UK.
University of Sheffield · GBAgency for Science, Technology and Research · SGCentro de Investigación en Materiales Avanzados · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dystroglycan is a ubiquitously expressed heterodimeric cell-surface laminin receptor with roles in cell adhesion, signalling, and membrane stabilisation. More recently, the transmembrane β-subunit of dystroglycan has been shown to localise to both the nuclear envelope and the nucleoplasm. This has led to the hypothesis that dystroglycan may have a structural role at the nuclear envelope analogous to its role at the plasma membrane. The biochemical fraction of myoblast cells clearly supports the presence of dystroglycan in the nucleus. Deletion of the dystroglycan protein by disruption of the

Indexed as

DystroglycansLamininCell MembraneCell NucleusNuclear EnvelopeDystroglycansLamininAFMdystroglycanmuscular dystrophiesmyoblastnucleus

Identifiers

PMID38474395
PMCPMC10931191
OpenAlexW4392295080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.